Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients – a three‐yr serial echocardiographic substudy of the randomized controlled CENTRAL trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|8|678-684

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.8, 2015-08, pp. : 678-684

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One‐Year Results of a Scandinavian Randomized Trial

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1967-1975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression of liver fibrosis in HCV‐positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 3, 2015-03 ,pp. : 373-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 8, 2015-08 ,pp. : 1056-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary Prevention of Skin Dysplasia in Renal Transplant Recipients With Photodynamic Therapy: A Randomized Controlled Trial

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 11, 2015-11 ,pp. : 2986-2990

John Wiley & Sons Inc

Access to resources Recommend Favorite

Protein Kinase C Inhibitor Sotrastaurin in De Novo Liver Transplant Recipients: A Randomized Phase II Trial

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 5, 2015-05 ,pp. : 1283-1292

John Wiley & Sons Inc

Access to resources Recommend Favorite